Covetrus Inc. [CVET] stock Upgrade by Stifel analyst, price target now $26

Covetrus Inc. [NASDAQ: CVET] traded at a low on 11/05/20, posting a -0.15 loss after which it closed the day’ session at $27.38. The company report on October 27, 2020 that Covetrus Announces Third Quarter 2020 Earnings Release Date and Conference Call Information.

Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced that it will release third quarter 2020 results after the market close on Tuesday, November 10, 2020. Following the release, the company will hold a conference call at 4:30 PM ET, during which Covetrus president and chief executive officer, Benjamin Wolin, and executive vice president and chief financial officer, Matthew Foulston, will review the results.

To access the live webcast of the conference call, individuals can visit the Investor Relations page of the Covetrus website: https://ir.covetrus.com/investors/events-and-presentations. An archived edition of the earnings conference call will also be posted on the Covetrus website later that day and will remain available to interested parties via the same link for one year.

The results of the trading session contributed to over 1624119 shares changing hands. Over the past one week, the price volatility of Covetrus Inc. stands at 4.49% while the volatility over the past one month is 4.71%.

The market cap for CVET stock reached $3.53 billion, with 112.00 million shares outstanding and 86.76 million shares in the current float. Compared to the average trading volume of 953.06K shares, CVET reached a trading volume of 1624119 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Covetrus Inc. [CVET]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVET shares is $23.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVET stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Stifel have made an estimate for Covetrus Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 16, 2020. While these analysts kept the previous recommendation, Goldman raised their target price to Sell. The new note on the price target was released on September 09, 2019, representing the official price target for Covetrus Inc. stock.

The Average True Range (ATR) for Covetrus Inc. is set at 1.27, with the Price to Sales ratio for CVET stock in the period of the last 12 months amounting to 0.86. The Price to Book ratio for the last quarter was 2.40, with the Price to Cash per share for the same quarter was set at 3.21. Price to Free Cash Flow for CVET in the course of the last twelve months was 31.53 with Quick ratio for the last quarter at 1.40.

How has CVET stock performed recently?

Covetrus Inc. [CVET] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.61. With this latest performance, CVET shares gained by 3.17% in over the last four-week period, additionally plugging by 132.03% over the last 6 months – not to mention a rise of 169.49% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVET stock in for the last two-week period is set at 63.97, with the RSI for the last a single of trading hit 65.50, and the three-weeks RSI is set at 61.67 for Covetrus Inc. [CVET]. The present Moving Average for the last 50 days of trading for this stock 24.12, while it was recorded at 26.47 for the last single week of trading, and 16.93 for the last 200 days.

Covetrus Inc. [CVET]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Covetrus Inc. [CVET] shares currently have an operating margin of -1.48 and a Gross Margin at +15.12. Covetrus Inc.’s Net Margin is presently recorded at -25.63.

Return on Total Capital for CVET is now -2.84, given the latest momentum, and Return on Invested Capital for the company is -51.40. Return on Equity for this stock declined to -74.12, with Return on Assets sitting at -36.43. When it comes to the capital structure of this company, Covetrus Inc. [CVET] has a Total Debt to Total Equity ratio set at 101.35. Additionally, CVET Total Debt to Total Capital is recorded at 50.34, with Total Debt to Total Assets ending up at 37.88. Long-Term Debt to Equity for the company is recorded at 94.90, with the Long-Term Debt to Total Capital now at 47.13.

Reflecting on the efficiency of the workforce at the company, Covetrus Inc. [CVET] managed to generate an average of -$185,273 per employee. Receivables Turnover for the company is 8.17 with a Total Asset Turnover recorded at a value of 1.42.Covetrus Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 2.10.

Earnings analysis for Covetrus Inc. [CVET]

With the latest financial reports released by the company, Covetrus Inc. posted 0.17/share EPS, while the average EPS was predicted by analysts to be reported at 0.07/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 142.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVET.

Insider trade positions for Covetrus Inc. [CVET]

There are presently around $3,059 million, or 88.70% of CVET stock, in the hands of institutional investors. The top three institutional holders of CVET stocks are: BLACKROCK INC. with ownership of 14,743,070, which is approximately 23.487% of the company’s market cap and around 0.20% of the total institutional ownership; MORGAN STANLEY, holding 11,870,110 shares of the stock with an approximate value of $325.0 million in CVET stocks shares; and CLAYTON, DUBILIER & RICE, LLC, currently with $303.17 million in CVET stock with ownership of nearly 0.057% of the company’s market capitalization.

Positions in Covetrus Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 123 institutional holders increased their position in Covetrus Inc. [NASDAQ:CVET] by around 13,770,015 shares. Additionally, 103 investors decreased positions by around 15,643,922 shares, while 62 investors held positions by with 82,315,669 shares. The mentioned changes placed institutional holdings at 111,729,606 shares, according to the latest SEC report filing. CVET stock had 52 new institutional investments in for a total of 5,641,752 shares, while 29 institutional investors sold positions of 1,558,057 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam